Skip to main content
. Author manuscript; available in PMC: 2023 Jul 12.
Published in final edited form as: N Engl J Med. 2022 Dec 14;388(2):128–141. doi: 10.1056/NEJMoa2207406

Table 1.

Characteristics of Patients with GAA-FGF14–Related Ataxia.*

Characteristic French Canadian (N = 68) German (N = 48) Australian (N = 3) Indian (N = 3) Overall (N = 122)

Male sex — no. (%) 32 (47) 24 (50) 3 (100) 3 (100) 62 (51)
Inheritance — no./total no. (%)
 Sporadic 10/68 (15) 22/44 (50) 2/3 (67) 2/3 (67) 36/118 (31)
 Familial 58/68 (85) 22/44 (50) 1/3 (33) 1/3 (33) 82/118 (69)
Episodic features — no./total no. (%) 47/67 (70) 6/48 (12) 1/3 (33) 2/3 (67) 56/121 (46)
Mean age at onset of episodes — yr 54±14 62±7 48 67 55±13
Mean age at onset of permanent ataxia — yr 59±12 60±11 57±11 62±9 59±11
Signs and symptoms — no./total no. (%)
 Nystagmus
  Downbeat nystagmus 43/65 (66) 5/48 (10) 0/3 (0) 2/3 (67) 50/119 (42)
  Gaze-evoked horizontal nystagmus 37/65 (57) 25/48 (52) 2/3 (67) 1/3 (33) 65/119 (55)
 Diplopia or visual blurring 39/66 (59) 16/48 (33) 0/3 (0) 2/3 (67) 57/120 (48)
 Cerebellar dysarthria 39/68 (57) 21/44 (48) 2/3 (67) 1/3 (33) 63/118 (53)
 Gait ataxia 65/68 (96) 42/44 (95) 3/3 (100) 3/3 (100) 113/118 (96)
 Appendicular ataxia 62/68 (91) 27/44 (61) 3/3 (100) 2/3 (67) 94/118 (80)
 Vertigo or dizziness 21/64 (33) 10/44 (23) 0/3 (0) 2/3 (67) 33/114 (29)
 Postural tremor 6/60 (10) 11/48 (23) 0/3 (0) 1/3 (33) 18/114 (16)
Cerebellar atrophy on MRI — no./total no. (%) 28/44 (64) 34/41 (83) 2/3 (67) 3/3 (100) 67/91 (74)
*

Plus–minus values are means ±SD. Clinical data from 122 of the 128 patients with GAA-FGF14–related ataxia are included. Six patients (2 male and 4 female) were excluded because clinical data of sufficient quality were not available. MRI denotes magnetic resonance imaging.

Data on age at onset of episodes of ataxia were missing for 2 patients, and data on age at onset of permanent ataxia were missing for 2 patients.

Data on age at onset of permanent ataxia were missing for 2 patients.